• OPEN AN ACCOUNT
Indian Indices
Sensex
78,954.76 373.76
( 0.48%)
Global Indices
Nasdaq
54,370.92 264.04
(0.49%)
Dow Jones
7,742.03 -15.49
(-0.20%)
Hang Seng
65,663.80 -636.64
(-0.96%)
Nikkei 225
10,873.25 -15.05
(-0.14%)
Forex
USD-INR
95.23 -0.06
(-0.07%)
EUR-INR
109.68 -0.11
(-0.10%)
GBP-INR
127.98 -0.19
(-0.15%)
JPY-INR
0.60 0.00
(-0.60%)

EQUITY - MARKET SCREENER

Cyient Ltd
Industry :  Computers - Software - Medium / Small
BSE Code
ISIN Demat
Book Value()
532175
INE136B01020
322.9631671
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
CYIENT
21.86
9606.54
EPS(TTM)
Face Value()
Div & Yield %
39.54
5
1.85
 

Concord Biotech's Unit II formulations unit successfully clears PPB and NDA inspection
Jun 25,2026
Concord Biotech announced the successful completion of inspection by the Pharmacy and Poisons Board (PPB) from Kenya and the National Drug Authority (NDA) from Uganda at Unit-II formulation facility. The inspection took place from 18 June 2026 to 24 June 2026, and was concluded successfully.